Diginex Ltd
No enriched coverage for $DGNX in the last 7 days.
No SEC Form 4 filings for $DGNX in the last 30 days.
This page provides an overview of Diginex Ltd (DGNX) stock performance, showing a current price of 1.205 USD, a drop of 2.03% (0.025 USD), and a market cap loss of 30.42M. It includes real-time and after-hours trading data, alongside general company information and a comment section. The article also outlines various resources available on TradingKey such as financial analysis tools, market news, and educational content.
Diginex (NASDAQ:DGNX) shares fell 7.1% in midday trading to $2.86 on light volume, trading significantly below its 50-day and 200-day moving averages. Analyst sentiment remains negative, with a consensus "Sell" rating. Despite the stock's weakness, several hedge funds and institutional investors began or increased small positions in Q3.
Diginex Limited (NASDAQ: DGNX) has signed a definitive agreement to acquire The Remedy Project, a Hong Kong-based advisory and research group specializing in labor and human rights in global supply chains. This acquisition aims to enhance Diginex's ESG compliance, supply chain due diligence, and verifiable remediation offerings, especially as regulatory frameworks like the EU CS3D become more stringent. The integration leverages The Remedy Project's expertise with Diginex's AI-powered platforms, positioning the company as a leader in comprehensive human rights due diligence.
